LIFESITE NEWS/ Steven Ertelt-
Multiple possible coronavirus vaccines that are on a fast track for development as the world awaits a vaccine to deal with the international pandemic. But one of the COVID-19 vaccines that is receiving the most attention is also the most controversial because it relies on cells from the body part of an aborted baby.
Despite a strong outcry from pro-life and Catholic leaders and despite ethical alternatives being available, a number of research teams still are using the cells from aborted babies in their work. These include Janssen Research & Development USA, a Johnson & Johnson subsidiary, and the University of Oxford and AstraZeneca, which could be the first to make a coronavirus vaccine available in the United States.
The Oxford/AstraZeneca team appears to be in first place in the vaccine race and doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of phase one of the clinical trial. A new paper published in The Lancet medical journal revealed the vaccine appears safe and induces a strong immune response following the first phase of human trials. It also appears to be helping the human body make antibodies by the body’s B cells, which is very helpful in staving off the virus in the future. Continue reading…
